 |
 |
South Staffordshire Joint Formulary
Cannock Chase Clinical Commissioning Group
East Staffordshire Clinical Commissioning Group
South East Staffordshire and Seisdon Peninsula Clinical Commissioning Group
Stafford and Surrounds Clinical Commissioning Group |
| Formulary Chapter 6: Endocrine system - Full Section
|
| Numbers in brackets indicate counts of (Formulary items, Non Formulary items)
|
|
06.01 |
Drugs used in diabetes
(0,0)
|
|
06.01.01 |
Insulins
(0,0)
|
|
06.01.01.01 |
Short-acting insulins
(8,6)
|
|
|
Rapid Acting Insulin Analogues
(0,0)
|
|
06.01.01.02 |
Intermediate- and long-acting insulins
(7,6)
|
|
|
Biphasic insulins
(4,3)
|
|
|
Intermediate Acting Insulin
(0,0)
|
|
|
Long Acting Insulin Analogues
(2,0)
|
|
06.01.01.03 |
Hypodermic equipment
(9,7)
|
|
06.01.02 |
Antidiabetic drugs
(0,0)
|
|
06.01.02.01 |
Sulphonyureas
(1,14)
|
|
06.01.02.02 |
Biguanides
(3,3)
|
|
06.01.02.03 |
Other antidiabetic drugs
(3,9)
|
|
|
DPP-4 inhibitors
(3,0)
|
|
|
GLP-1 mimetics
(6,0)
|
|
|
SGLT2 inhibitors
(7,0)
|
|
06.01.02.07 |
Other antidiabetic drugs
(0,0)
|
|
06.01.03 |
Diabetic ketoacidosis
(0,0)
|
|
06.01.04 |
Treatment of hypoglycaemia
(1,3)
|
|
06.01.05 |
Treatment of diabetic nephropathy and neuropathy
(0,0)
|
|
06.01.06 |
Diagnostic and monitoring agents for diabetes mellitus
(2,0)
|
|
06.02 |
Thyroid and Antithyroid drugs
(0,0)
|
|
06.02.01 |
Thyroid hormones
(3,1)
|
|
06.02.02 |
Antithyroid drugs
(2,1)
|
|
06.03 |
Corticosteroids
(1,0)
|
|
06.03.01 |
Replacement therapy
(1,0)
|
|
06.03.02 |
Glucocorticoid therapy
(4,10)
|
|
06.04 |
Sex hormones
(0,0)
|
|
06.04.01 |
Female sex hormones and their modulators
(0,1)
|
|
06.04.01.01 |
Oestrogens and HRT
(9,38)
|
|
06.04.01.02 |
Progestogens
(5,10)
|
|
06.04.02 |
Male sex hormones and antagonists
(5,10)
|
|
|
Anti-androgens
(2,2)
|
|
06.04.03 |
Anabolic steroids
(1,1)
|
|
06.05 |
Hypothalamic and pituitary hormones and anti-oestrogens
(0,1)
|
|
06.05.01 |
Hypothalamic and anterior pituitary hormones and anti-oestrogens
(0,0)
|
|
|
Anti-oestrogens
(1,0)
|
|
|
Anterior pituitary hormones
(1,12)
|
|
|
Gonadotrophins
(0,0)
|
|
|
Growth Hormone
(0,0)
|
|
|
Growth hormone receptor antagonists
(0,0)
|
|
|
Thyrotropin
(0,0)
|
|
06.05.02 |
Posterior pituitary hormones and antagonists
(2,0)
|
|
|
Posterior pituitary hormones
(1,7)
|
|
06.06 |
Drugs affecting bone metabolism
(0,0)
|
|
|
Osteoporosis
(0,0)
|
|
06.06.01 |
Calcitonin and parathyroid hormone
(3,0)
|
|
06.06.02 |
Bisphosphonates and other drugs affecting bone metabolism
(0,0)
|
|
|
Bisphosphonates
(9,9)
|
|
|
Denosumab
(2,0)
|
|
06.07 |
Other endocrine drugs
(0,0)
|
|
06.07.01 |
Bromocriptine and other dopaminergic drugs
(0,3)
|
|
06.07.02 |
Drugs affecting gonadotrophins
(1,4)
|
|
06.07.03 |
Metyrapone
(0,2)
|
|
06.07.04 |
Somatomedins
(0,1)
|
|
|
|
